<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="glc" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">glc</book-part-id>
      <title-group>
        <title>Primary Congenital Glaucoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Abu-Amero</surname>
            <given-names>Khaled K</given-names>
          </name>
          <degrees>PhD, FRCPath</degrees>
          <aff>Department of Ophthalmology<break/>College of Medicine<break/>King Saud University<break/>Riyadh, Saudi Arabia<break/>Department of Ophthalmology and Visual Sciences<break/>University of Illinois at Chicago<break/>Chicago, Illinois</aff>
          <email>abuamero@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Edward</surname>
            <given-names>Deepak P</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Ophthalmology and Visual Sciences<break/>University of Illinois at Chicago<break/>Chicago, Illinois<break/>King Khaled Eye Specialist Hospital<break/>Riyadh, Saudi Arabia</aff>
          <email>deepak.edward@gmail.com</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>30</day>
          <month>9</month>
          <year>2004</year>
        </date>
        <date date-type="updated">
          <day>17</day>
          <month>8</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>25</day>
          <month>8</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="coq10-def" document-type="chapter">Primary Coenzyme Q<sub>10</sub> Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="pfcp" document-type="chapter">Primary Familial and Congenital Polycythemia</related-object>
      <abstract id="glc.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab&#x02019;s striae), thinning of the anterior sclera and iris atrophy, anomalously deep anterior chamber, and structurally normal posterior segment except for progressive glaucomatous optic atrophy. Symptoms include photophobia, blepharospasm, and excessive tearing. Typically, the diagnosis is made in the first year of life. Depending on when treatment is instituted, visual acuity may be reduced and/or visual fields may be restricted. In untreated individuals, blindness invariably occurs.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of PCG is based on clinical criteria including: elevated IOP in a child typically before age one year, enlargement of the globe, increased corneal diameter, cloudy corneas, breaks in Decsemet&#x02019;s membrane (Haab&#x02019;s striae) and anomalously deep anterior chamber. Identification of biallelic pathogenic variants in <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic> or identification of a heterozygous pathogenic variant in <italic toggle="yes">TEK</italic> confirms the diagnosis if clinical features are inconclusive.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Surgery (goniotomy, trabeculotomy, trabeculectomy, or deep sclerectomy) as early as possible; use of drainage implants or cyclodestruction if surgery fails; medication preoperatively and postoperatively to help control IOP; routine treatment of refractive errors and amblyopia.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Discontinuation of medications such as Phospholine Iodide<sup>&#x000ae;</sup> (echothiophate) before surgery to prevent prolonged apnea.</p>
          <p><italic toggle="yes">Surveillance</italic>: Lifelong monitoring to ensure control of IOP.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Alpha-2 agonists because of risk for apnea and bradycardia.</p>
          <p><italic toggle="yes">Evaluation of relatives</italic>
<italic toggle="yes">at risk</italic>: If the pathogenic variant(s) have been identified in the family, molecular genetic testing of at-risk sibs as soon as possible after birth in order to avoid repeated examinations under anesthesia in young children who do not have the pathogenic variant(s).</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>PCG caused by biallelic pathogenic variants in <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic> is inherited in an autosomal recessive manner. PCG caused by a heterozygous pathogenic variant in <italic toggle="yes">TEK</italic> is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec>
          <title>Autosomal recessive inheritance</title>
          <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Heterozygotes (carriers) are asymptomatic; carrier testing for at-risk family members is possible if the pathogenic variants in the family are known.</p>
        </sec>
        <sec>
          <title>Autosomal dominant inheritance</title>
          <p>Each child of an individual with <italic toggle="yes">TEK</italic>-related PCG has a 50% chance of inheriting the pathogenic variant.</p>
          <p>Prenatal diagnosis for pregnancies at increased risk is possible if the PCG-causing pathogenic variant(s) in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="glc.Diagnosis">
        <title>Diagnosis</title>
        <sec id="glc.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Primary congenital glaucoma (PCG) <bold>should be suspected</bold> in infants or children with the following clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Photophobia, blepharospasm, and excessive tearing</p>
            </list-item>
            <list-item>
              <p>Edema and opacification of the cornea with rupture of Descemet's membrane, known as Haab's striae</p>
            </list-item>
            <list-item>
              <p>Thinning of the anterior sclera and atrophy of the iris</p>
            </list-item>
            <list-item>
              <p>Structurally normal posterior segment except for progressive optic atrophy</p>
            </list-item>
            <list-item>
              <p>Absence of structural changes in the anterior chamber that are consistent with a diagnosis of anterior segment dysgenesis or associated systemic disease.</p>
            </list-item>
          </list>
        </sec>
        <sec id="glc.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of PCG <bold>is established</bold> in a proband by the following clinical criteria:</p>
          <list list-type="bullet">
            <list-item>
              <p>Elevated intraocular pressure (IOP) in an infant or child typically (but not always) before age one year. An IOP greater than 21 mm Hg (mercury) in one or both eyes as measured by applanation tonometry, I-care tonometry<sup>&#x02122;</sup>, or pneumotonometry on at least two occasions is considered abnormally elevated. In general, normal intraocular pressure in children is 12.02 &#x000b1; 3.74 mm Hg [<xref ref-type="bibr" rid="glc.REF.sihota.2006.14">Sihota et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Enlargement of the (infantile) globe (buphthalmos)</p>
            </list-item>
            <list-item>
              <p>Increased corneal diameter and cloudy corneas</p>
            </list-item>
            <list-item>
              <p>Breaks in Decsemet&#x02019;s membrane (Haab&#x02019;s striae)</p>
            </list-item>
            <list-item>
              <p>Anomalously deep anterior chamber</p>
            </list-item>
            <list-item>
              <p>Bilateral or unilateral findings</p>
            </list-item>
          </list>
          <p>Identification of biallelic pathogenic variants in <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic> or a heterozygous <italic toggle="yes">TEK</italic> pathogenic variant on molecular genetic testing (see Table 1) confirms the diagnosis if clinical features are inconclusive.</p>
          <p>Molecular testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serial single-gene testing</bold>. Perform sequence analysis of <italic toggle="yes">CYP1B1,</italic> followed by deletion/duplication analysis if only one or no pathogenic variant is found. If no <italic toggle="yes">CYP1B1</italic> pathogenic variants are identified, consider sequence analysis of <italic toggle="yes">LTBP2</italic>. Sequence analysis and gene-targeted deletion/duplication analysis of <italic toggle="yes">TEK</italic> can be considered next if one or no pathogenic has been identified.</p>
              <p>Targeted analysis for:</p>
              <list list-type="bullet">
                <list-item>
                  <p><italic toggle="yes">CYP1B1</italic> pathogenic variant p.Glu387Lys may be performed first in individuals of Rom Slovakian ancestry;</p>
                </list-item>
                <list-item>
                  <p><italic toggle="yes">CYP1B1</italic> pathogenic variant p.Glu387Lys may be performed first in individuals of Saudi Arabian ancestry.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CYP1B1, LTBP2, TEK</italic>, and other genes of interest (see <xref ref-type="sec" rid="glc.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="glc.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Primary Congenital Glaucoma</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_2">Proportion of PGC Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CYP1B1</italic>
                  </td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20%-100% of familial cases&#x000a0;<sup>5</sup><break/>10%-15% of simplex cases&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~ 90%-95%</td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~5%-10%&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">LTBP2</italic>
                  </td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02264;40%&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~100%</td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>9</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">TEK</italic>
                  </td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">10 families&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">9/10 families</td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">1 family</td>
                </tr>
                <tr>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>11,&#x000a0;12</sup></td>
                  <td headers="hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_2 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_glc.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" colspan="3" align="left" rowspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="glc.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="glc" object-id="glc.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="glc.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="glc.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="glc.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="glc.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="glc.TF.1.5">
                <label>5. </label>
                <p>The probability of identifying pathogenic variants in <italic toggle="yes">CYP1B1</italic> increases with the presence of: positive family history, parental consanguinity, and bilateral and severe disease. Differences in the number of individuals studied, the methods of ascertainment (familial vs. simplex cases, unilateral vs. bilateral disease), and the molecular genetic testing methods used make accurate estimates of variant detection frequency difficult.</p>
              </fn>
              <fn id="glc.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="glc.REF.mashima.2001.2211">Mashima et al [2001]</xref>, <xref ref-type="bibr" rid="glc.REF.stoilov.2002.1820">Stoilov et al [2002]</xref>, <xref ref-type="bibr" rid="glc.REF.curry.2004.3">Curry et al [2004]</xref></p>
              </fn>
              <fn id="glc.TF.1.7">
                <label>7. </label>
                <p>At least five <italic toggle="yes">CYP1B1</italic> alleles with gross deletions, sometimes including the entire <italic toggle="yes">CYP1B1</italic> along with adjacent genes, have been reported. Additionally, gross duplications and a complex mutational event are known. For details see Molecular Genetics, <related-object source-id="gene" document-id="glc" object-id="glc.molgen.TA">Table A</related-object>, <bold>LSDB</bold> and <bold>HGMD</bold>.</p>
              </fn>
              <fn id="glc.TF.1.8">
                <label>8. </label>
                <p><xref ref-type="bibr" rid="glc.REF.ali.2009.664">Ali et al [2009]</xref>, <xref ref-type="bibr" rid="glc.REF.narooienejad.2009.3969">Narooie-Nejad et al [2009]</xref>, <xref ref-type="bibr" rid="glc.REF.micheal.2016.e0159259">Micheal et al [2016]</xref></p>
              </fn>
              <fn id="glc.TF.1.9">
                <label>9. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
              <fn id="glc.TF.1.10">
                <label>10. </label>
                <p>Heterozygous <italic toggle="yes">TEK</italic> pathogenic variants were identified in affected individuals from 10/189 unrelated families with PCG [<xref ref-type="bibr" rid="glc.REF.souma.2016.2575">Souma et al 2016</xref>].</p>
              </fn>
              <fn id="glc.TF.1.11">
                <label>11. </label>
                <p><xref ref-type="bibr" rid="glc.REF.kaur.2005.335">Kaur et al [2005]</xref> presented evidence in a single individual that the combination of a heterozygous pathogenic variant in <italic toggle="yes">MYOC</italic> and a heterozygous pathogenic variant in <italic toggle="yes">CYP1B1</italic> was associated with PCG, suggesting digenic inheritance. A report of a Chinese family segregating both primary congenital open-angle glaucoma (POAG) and PCG suggested that homozygous <italic toggle="yes">MYOC</italic> variants may cause PCG [<xref ref-type="bibr" rid="glc.REF.zhuo.2006.1210">Zhuo et al 2006</xref>].</p>
              </fn>
              <fn id="glc.TF.1.12">
                <label>12. </label>
                <p>Two additional loci, GLC3B on 1p36 [<xref ref-type="bibr" rid="glc.REF.akarsu.1996.1199">Akarsu et al 1996</xref>] and GLC3C on 14q24.3 [<xref ref-type="bibr" rid="glc.REF.stoilov.2002">Stoilov &#x00026; Sarfarazi 2002</xref>], have been linked to PCG; however, the genes at these loci are not known. One additional locus linked to PCG, on 14q24.2-q24.3, does not appear to overlap the GLC3C critical region [<xref ref-type="bibr" rid="glc.REF.firasat.2008.1659">Firasat et al 2008</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="glc.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="glc.Clinical_Description">
          <title>Clinical Description</title>
          <p>Primary congenital glaucoma (PCG) is characterized by developmental defect(s) of the trabecular meshwork and anterior chamber angle that prevent adequate drainage of aqueous humor, resulting in elevated intraocular pressure (IOP) and stretching of the sclera that produces an enlarged globe (buphthalmos).</p>
          <p>The following information comes from the detailed clinical papers on PCG of <xref ref-type="bibr" rid="glc.REF.deluise.1983.1">deLuise &#x00026; Anderson [1983]</xref> and <xref ref-type="bibr" rid="glc.REF.ho.2004.271">Ho &#x00026; Walton [2004]</xref> unless otherwise noted.</p>
          <p>By definition, congenital glaucoma is present at birth; it is typically diagnosed in the first year of life. PCG is more common in males (65%) and is bilateral in 70% of individuals.</p>
          <p>The clinical signs and symptoms depend primarily on the age of onset and the severity of the disease. The classic symptoms include tearing, photophobia, and irritability. Occasionally, parents may notice cloudy and/or unusually large corneas in their child caused by corneal edema; the corneal enlargement generally occurs before age three years.</p>
          <p>The most severe clinical features are typically seen in the newborn, who may present with corneal opacity, increased corneal diameter, increased IOP, and an enlarged globe [<xref ref-type="bibr" rid="glc.REF.walton.1998">Walton 1998</xref>]. In 35 newborns with PCG, corneal edema was present in 100% of the eyes, either as diffuse (90%) or localized (10%) opacity [<xref ref-type="bibr" rid="glc.REF.walton.1998">Walton 1998</xref>].</p>
          <p>Early detection and appropriate treatment of congenital glaucoma can improve visual outcome. In contrast to the permanent optic nerve cupping and visual field loss seen in adults with adult-onset glaucoma, the pressure-induced optic nerve cupping in infants and young children with PCG is reversible, particularly in the early stages of the disease. This favorable outcome is believed to be a result of the highly elastic nature of the tissues of the optic nerves of infants and young children [<xref ref-type="bibr" rid="glc.REF.allingham.2005">Allingham et al 2005</xref>]. A delay in treatment can result in reduced visual acuity and/or restricted visual fields. In untreated individuals, blindness invariably occurs.</p>
          <p>The ultimate visual outcome depends on the severity of the disease at diagnosis, the presence of other associated ocular abnormalities, response to surgical treatment, and success in controlling IOP on follow up. The earlier the onset of clinical manifestations of glaucoma, the worse the prognosis.</p>
          <p>Despite early treatment and multiple surgical interventions, some individuals with severe disease evident at birth develop significant visual impairment from corneal opacification, advanced glaucomatous damage, or amblyopia, and may eventually become legally blind.</p>
          <p>Individuals with milder forms of disease who present later in childhood often do well with a single surgical procedure and have an excellent visual prognosis later in life.</p>
          <p>The IOP is a significant prognostic factor for postoperative visual function, with substantially better vision observed in individuals with IOP &#x0003c;19 mm Hg.</p>
        </sec>
        <sec id="glc.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p><bold><italic toggle="yes">CYP1B1.</italic></bold> Individuals with <italic toggle="yes">CYP1B1</italic> pathogenic variants needed significantly more surgical procedures to control intraocular pressure than individuals with congenital glaucoma of unknown cause, when both eyes of an individual were evaluated (<italic toggle="yes">P</italic>=0.003) or the worst eye was evaluated (<italic toggle="yes">P</italic>=0.011) [<xref ref-type="bibr" rid="glc.REF.della_paolera.2010.176">Della Paolera et al 2010</xref>]. The correlations with genotype have been inconsistent.</p>
          <p>Individuals with <italic toggle="yes">CYP1B1</italic> pathogenic variants tend to have a higher operative success rate than individuals without identified <italic toggle="yes">CYP1B1</italic> pathogenic variants in terms of better intraocular pressure control effect. Together, the presence or absence of pathogenic variants in <italic toggle="yes">CYP1B1</italic> and the preoperative corneal opacity score can partially predict the outcome of PCG surgery [<xref ref-type="bibr" rid="glc.REF.chen.2014b.246">Chen et al 2014b</xref>].</p>
          <p>Individuals with <italic toggle="yes">CYP1B1</italic> pathogenic variants had higher last postoperative visit indices in terms of postoperative haze and the need for anti-glaucoma medications than individuals without pathogenic variants in <italic toggle="yes">CYP1B1</italic> [<xref ref-type="bibr" rid="glc.REF.abuamero.2011.2911">Abu-Amero et al 2011</xref>].</p>
          <p><bold><italic toggle="yes">LTBP2</italic>.</bold> Individuals with <italic toggle="yes">LTBP2-</italic>related PCG had clinical features not seen in individuals with pathogenic variants in <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">TEK</italic>; these features included ectopia lentis, high arched palate, and mild-to-moderate osteopenia [<xref ref-type="bibr" rid="glc.REF.ali.2009.664">Ali et al 2009</xref>].</p>
          <p><bold><italic toggle="yes">TEK</italic>.</bold> Individuals with <italic toggle="yes">TEK</italic>-related congenital glaucoma exhibit a clinical phenotype that is variable in severity and age of onset [<xref ref-type="bibr" rid="glc.REF.souma.2016.2575">Souma et al 2016</xref>].</p>
        </sec>
        <sec id="glc.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Walton and colleagues have shown that the phenotype can vary significantly in the same individual (one eye being more severely affected than the other) [<xref ref-type="bibr" rid="glc.REF.walton.1998">Walton 1998</xref>].</p>
          <p><bold><italic toggle="yes">CYP1B1</italic>.</bold> No consistent genotype-phenotype correlation has been observed for <italic toggle="yes">CYP1B1</italic> pathogenic variants. Intra- and interfamilial variability is reported among individuals with identical <italic toggle="yes">CYP1B1</italic> pathogenic variants [<xref ref-type="bibr" rid="glc.REF.berraho.2015.297">Berraho et al 2015</xref>, <xref ref-type="bibr" rid="glc.REF.de_melo.2015.e0127147">de Melo et al 2015</xref>]. No information is available on correlation between the <italic toggle="yes">CYP1B1</italic> pathogenic variants and the success of surgical therapy.</p>
          <p><bold><italic toggle="yes">LTBP2.</italic></bold> No genotype-phenotype correlation has been observed for <italic toggle="yes">LTBP2</italic> pathogenic variants.</p>
          <p><bold><italic toggle="yes">TEK</italic>.</bold> No genotype-phenotype correlation has been observed for <italic toggle="yes">TEK</italic> pathogenic variants.</p>
        </sec>
        <sec id="glc.Prevalence">
          <title>Prevalence</title>
          <p><bold><italic toggle="yes">CYP1B1</italic>.</bold> The prevalence of <italic toggle="yes">CYP1B1</italic> pathogenic variants in individuals with PCG varies: 20% in Japanese [<xref ref-type="bibr" rid="glc.REF.pl_silov_.1999.290">Pl&#x000e1;silov&#x000e1; et al 1999</xref>], 33.3% in Indonesians [<xref ref-type="bibr" rid="glc.REF.sitorus.2003.e9">Sitorus et al 2003</xref>], 44% among Indians [<xref ref-type="bibr" rid="glc.REF.chakrabarti.2010.4083">Chakrabarti et al 2010</xref>], 50% among Brazilians [<xref ref-type="bibr" rid="glc.REF.stoilov.2002.1820">Stoilov et al 2002</xref>], 70% in Iranians [<xref ref-type="bibr" rid="glc.REF.chitsazian.2007.382">Chitsazian et al 2007</xref>], and 80%-100% among Saudi Arabians [<xref ref-type="bibr" rid="glc.REF.bejjani.2000.367">Bejjani et al 2000</xref>, <xref ref-type="bibr" rid="glc.REF.abuamero.2011.2911">Abu-Amero et al 2011</xref>] and the Rom Slovakian population [<xref ref-type="bibr" rid="glc.REF.pl_silov_.1999.290">Pl&#x000e1;silov&#x000e1; et al 1999</xref>]. The relatively higher prevalence of these pathogenic variants in the latter two populations could be attributed to consanguinity.</p>
          <p>Some pathogenic variants are more common in specific ethnic groups. For example:</p>
          <list list-type="bullet">
            <list-item>
              <p>p.Glu387Lys accounts for all the pathogenic variants in the Rom Slovakian population.</p>
            </list-item>
            <list-item>
              <p>p.Gly61Glu accounts for 72% of the pathogenic variants in Saudi Arabians [<xref ref-type="bibr" rid="glc.REF.bejjani.1998.325">Bejjani et al 1998</xref>].</p>
            </list-item>
          </list>
          <p>Additional pathogenic variants have been associated (although with lesser frequencies) with other specific ethnic groups [<xref ref-type="bibr" rid="glc.REF.belmouden.2002.334">Belmouden et al 2002</xref>, <xref ref-type="bibr" rid="glc.REF.panicker.2002.1358">Panicker et al 2002</xref>, <xref ref-type="bibr" rid="glc.REF.chakrabarti.2006.43">Chakrabarti et al 2006</xref>].</p>
          <p>PCG occurs in all ethnic groups. The birth prevalence, however, varies worldwide:</p>
          <list list-type="bullet">
            <list-item>
              <p>1:5,000-22,000 in western countries</p>
            </list-item>
            <list-item>
              <p>1:2,500 in the Middle East</p>
            </list-item>
            <list-item>
              <p>1:1,250 in the Rom population of Slovakia [<xref ref-type="bibr" rid="glc.REF.pl_silov_.1998.30">Pl&#x000e1;silov&#x000e1; et al 1998</xref>]</p>
            </list-item>
            <list-item>
              <p>1:3,300 in the Indian state of Andhra Pradesh, where the disease accounts for approximately 4.2% of all childhood blindness [<xref ref-type="bibr" rid="glc.REF.dandona.2001.908">Dandona et al 2001</xref>]</p>
            </list-item>
          </list>
          <p>In Saudi Arabia and in the Rom population of Slovakia, PCG is the most common cause of childhood blindness [<xref ref-type="bibr" rid="glc.REF.pl_silov_.1998.30">Pl&#x000e1;silov&#x000e1; et al 1998</xref>, <xref ref-type="bibr" rid="glc.REF.bejjani.2000.367">Bejjani et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="glc.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <sec id="glc.CYP1B1">
          <title>
            <italic toggle="yes">CYP1B1</italic>
          </title>
          <p><italic toggle="yes">CYP1B1-</italic>related congenital glaucoma can be associated with an extreme form of anterior segment dysgenesis that includes recalcitrant glaucoma, corneal opacification, juvenile [<xref ref-type="bibr" rid="glc.REF.abuamero.2015.184">Abu-Amero et al 2015</xref>] and adult open-angle glaucoma [<xref ref-type="bibr" rid="glc.REF.micheal.2015.31">Micheal et al 2015</xref>], and aniridia [<xref ref-type="bibr" rid="glc.REF.alzuhairy.2015.89">Alzuhairy et al 2015</xref>].</p>
          <p><bold>Primary open-angle glaucoma (POAG).</bold>
<italic toggle="yes">CYP1B1</italic> pathogenic variants have been reported in individuals of French ancestry with POAG, suggesting that <italic toggle="yes">CYP1B1</italic> pathogenic variants could pose a significant risk for early-onset POAG and could also modify the glaucoma phenotype in individuals who do not have an <italic toggle="yes">MYOC</italic> pathogenic variant [<xref ref-type="bibr" rid="glc.REF.melki.2004.647">Melki et al 2004</xref>].</p>
          <p><bold>Congenital anterior staphylomas.</bold>
<italic toggle="yes">CYP1B1</italic> pathogenic variants may be associated with congenital anterior staphylomas [<xref ref-type="bibr" rid="glc.REF.al_judaibi.2014.445">Al Judaibi et al 2014</xref>].</p>
          <p><bold>Peters anomaly.</bold> Pathogenic variants in <italic toggle="yes">CYP1B1</italic> have been described in individuals with Peters anomaly (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604229">604229</ext-link>), a uni- or bilateral developmental disorder of the anterior chamber that is distinct from PCG. Clinical findings in Peters anomaly include central corneal opacity associated with corneal stromal thinning, absence of varying lengths of central Descemet's membrane, and iridocorneal and/or keratolenticular adhesions.</p>
          <p><bold>Juvenile open-angle glaucoma (JOAG).</bold>
<italic toggle="yes">CYP1B1</italic> pathogenic variants have also been implicated in three individuals with JOAG (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/137750">137750</ext-link>) [<xref ref-type="bibr" rid="glc.REF.vincent.2002.448">Vincent et al 2002</xref>]. In that study, a family with autosomal dominant glaucoma showed cosegregation of a pathogenic variant in <italic toggle="yes">MYOC</italic> and a pathogenic variant in <italic toggle="yes">CYP1B1</italic> in an individual with more severe disease. Pathogenic variants in <italic toggle="yes">MYOC</italic> may, in conjunction with pathogenic variants in <italic toggle="yes">CYP1B1,</italic> increase the clinical severity of glaucoma in individuals with JOAG. Indeed, individuals who are heterozygous for a pathogenic variant in both <italic toggle="yes">MYOC</italic> and <italic toggle="yes">CYP1B1</italic> appear to have a more severe open-angle glaucoma phenotype than those who are heterozygous for a pathogenic variant in <italic toggle="yes">MYOC</italic> alone [<xref ref-type="bibr" rid="glc.REF.vincent.2002.448">Vincent et al 2002</xref>]. These results suggest that <italic toggle="yes">CYP1B1</italic> may act as a modifier of <italic toggle="yes">MYOC</italic> expression and that these two genes may interact through a common pathway [<xref ref-type="bibr" rid="glc.REF.vincent.2002.448">Vincent et al 2002</xref>].</p>
          <p><xref ref-type="bibr" rid="glc.REF.acharya.2006.399">Acharya et al [2006]</xref> suggested that on rare occasions homozygous <italic toggle="yes">CYP1B1</italic> pathogenic variants alone (i.e., without <italic toggle="yes">MYOC</italic> pathogenic variants) may cause JOAG.</p>
          <p>In the study of <xref ref-type="bibr" rid="glc.REF.abuamero.2015.184">Abu-Amero et al [2015]</xref>:</p>
          <list list-type="bullet">
            <list-item>
              <p>12 of 14 unrelated Saudi Arabians with JOAG had at least one <italic toggle="yes">CYP1B1</italic> variant.</p>
            </list-item>
            <list-item>
              <p>Eight were homozygous for the p.Gly61Glu pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Two were compound heterozygous for the p.Gly61Glu and p.Leu432Val variants.</p>
            </list-item>
            <list-item>
              <p>Two were heterozygous for the p.Gly61Glu variant with no other variant identified.</p>
            </list-item>
          </list>
          <p>No genotype-phenotype correlation was demonstrated in those with biallelic <italic toggle="yes">CYP1B1</italic> pathogenic variants. None of the 14 had mutation of <italic toggle="yes">MYOC</italic> or <italic toggle="yes">LTBP2</italic>.</p>
        </sec>
        <sec id="glc.LTBP2">
          <title>
            <italic toggle="yes">LTBP2</italic>
          </title>
          <p><xref ref-type="bibr" rid="glc.REF.kumar.2010.365">Kumar et al [2010]</xref> detected a homozygous <italic toggle="yes">LTBP2</italic> pathogenic variant in one family with microspherophakia. <italic toggle="yes">LTBP2</italic> pathogenic variants have also been associated with <related-object link-type="booklink" source-id="gene" document-id="weill-ms" document-type="chapter">Weill-Marchesani syndrome</related-object>. Homozygous <italic toggle="yes">LTBP2</italic> pathogenic variants were identified in eight individuals with congenital megalocornea from three families [<xref ref-type="bibr" rid="glc.REF.khan.2011.2570">Khan et al 2011</xref>].</p>
        </sec>
        <sec id="glc.TEK">
          <title>
            <italic toggle="yes">TEK</italic>
          </title>
          <p>Heterozygous <italic toggle="yes">TEK</italic> pathogenic variants have been identified in multiple individuals with hereditary and sporadic venous malformations.</p>
        </sec>
      </sec>
      <sec id="glc.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A number of congenital ocular conditions can mimic PCG and must be considered by the clinician [<xref ref-type="bibr" rid="glc.REF.khan.2011.129">Khan 2011</xref>]. For example, the nonspecific findings of tearing and redness of the eyes may mimic more common conditions such as conjunctivitis or congenital nasolacrimal duct obstruction; ocular irritation with photophobia and redness may mimic the more frequent problem of corneal abrasion.</p>
        <p><bold>Congenital glaucoma</bold> can be subcategorized by age of onset into the following three types:</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary "newborn"-type congenital glaucoma. The most severe type; clinically apparent between birth and age one month</p>
          </list-item>
          <list-item>
            <p>Primary "infantile" glaucoma (or infantile PCG) as described by <xref ref-type="bibr" rid="glc.REF.walton.2005.333">Walton &#x00026; Katsavounidou [2005]</xref>. Clinically recognized between age one month and two years</p>
          </list-item>
          <list-item>
            <p>"Juvenile" ("late-recognized") primary infantile glaucoma. Onset clinically apparent after age two years</p>
          </list-item>
        </list>
        <p>The types do not correlate with a specific genetic cause, although primary "newborn"-type congenital glaucoma is more likely to be caused by mutation of <italic toggle="yes">CYP1B1</italic> than the other types of congenital glaucoma in some populations.</p>
        <p>In the older child with juvenile onset, or in less severely affected individuals, the increase in intraocular pressure (IOP) is gradual; thus, corneal edema and opacity may be less obvious than in the newborn type. Progressive enlargement of the globe or "buphthalmos" usually does not occur after age three to four years [<xref ref-type="bibr" rid="glc.REF.ho.2004.271">Ho &#x00026; Walton 2004</xref>, <xref ref-type="bibr" rid="glc.REF.allingham.2005">Allingham et al 2005</xref>].</p>
        <p><bold>Conditions/syndromes associated with infantile glaucoma.</bold> A number of well-recognized conditions and syndromes may present with infantile glaucoma, along with other ocular and/or systemic findings. Some conditions may not be compatible with life (e.g., trisomy 13, trisomy 18, Walker-Warburg syndrome [see <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">Congenital Muscular Dystrophy Overview</related-object>], and <related-object link-type="booklink" source-id="gene" document-id="pbd" document-type="chapter">Zellweger Syndrome</related-object>); others may be less severe or confined only to the eye.</p>
        <p>It is important to establish the diagnosis of an associated syndrome because of the implications for genetic counseling and treatment (see <xref ref-type="table" rid="glc.T.conditionssyndromes_associated_wit">Table 2</xref>).</p>
        <table-wrap id="glc.T.conditionssyndromes_associated_wit" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Conditions/Syndromes Associated with Infantile Glaucoma</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1">Disorder</th>
                <th id="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2">Gene(s)</th>
                <th id="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3">MOI</th>
                <th id="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Features</th>
              </tr>
              <tr>
                <th headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4" id="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Eye Findings</th>
                <th headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4" id="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Other</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="aniridia" document-type="chapter">Aniridia</related-object>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">PAX6</italic><break/><italic toggle="yes">WT1</italic>&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Complete or partial iris hypoplasia w/associated foveal hypoplasia, resulting in reduced visual acuity &#x00026; nystagmus</p></list-item><list-item><p>Presents in early infancy</p></list-item><list-item><p>Frequently associated w/other ocular abnormalities, often of later onset, incl cataract, glaucoma, &#x00026; corneal opacification&#x00026; vascularization</p></list-item></list>
</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">May occur either as an isolated ocular abnormality w/out systemic involvement or as part of WAGR syndrome&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Anterior segment dysgenesis syndromes<break/>(e.g., <related-object link-type="booklink" source-id="gene" document-id="peters-plus" document-type="chapter">Peters Plus syndrome</related-object>)</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" colspan="2" align="left" rowspan="1">See footnote 2</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Phenotypically &#x00026; genotypically distinct from PCG in general, but severe or advanced PCG can be difficult to distinguish clinically from some of the anterior segment dysgenesis syndromes; e.g., Peters anomaly</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="peters-plus" document-type="chapter">Peters Plus syndrome</related-object>: developmental delay, mild to severe ID, cleft lip, cleft palate</td>
              </tr>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Axenfeld-Rieger anomaly (anterior segment disorder)</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FOXC1</italic>
                  <break/>
                  <italic toggle="yes">PITX2</italic>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Presents w/posterior embryotoxon &#x00026; (variably) iris strands adherent to Schwalbe's line, iris hypoplasia, focal iris atrophy, &#x00026; ectropion uveae.</p></list-item><list-item><p>Glaucoma develops in ~50% of affected individuals but is more common in those w/central iris changes &#x00026; marked anterior iris insertion</p></list-item><list-item><p>Always bilateral, but may be distinctly asymmetric</p></list-item></list>
</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">May occur in the setting of Axenfeld-Rieger syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/180500">180500</ext-link>): dysmorphic features, dental anomalies, sensorineural hearing loss, cardiac malformations, endocrine &#x00026; orthopedic abnormalities</td>
              </tr>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Microcornea</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" colspan="2" align="left" rowspan="1">Unknown&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Corneal diameter &#x0003c;10 mm</p></list-item><list-item><p>Can be associated w/glaucoma &#x00026; other ocular anomalies incl congenital cataracts, sclerocornea, &#x00026; corneal plana</p></list-item></list>
</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">May be a feature of systemic syndromes</td>
              </tr>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Congenital hereditary endothelial dystrophy (CHED; OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/217700">217700</ext-link>)</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SLC4A11</italic>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Bilateral corneal opacification</p></list-item><list-item><p>May be difficult to distinguish from microcornea, but corneal diameter &#x00026; IOP are usually normal in CHED</p></list-item><list-item><p>The primary defect in the corneal endothelium leads to corneal edema &#x00026; opacification.</p></list-item><list-item><p>CHED &#x00026; CG are known to coexist; exact incidence unknown&#x000a0;<sup>4</sup></p></list-item></list>
</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Sensorineural hearing loss</td>
              </tr>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="lowe" document-type="chapter">Lowe syndrome</related-object>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">OCRL</italic>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XL</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Dense congenital cataracts are found in all affected boys, infantile glaucoma in ~50%</p></list-item><list-item><p>All boys have impaired vision; corrected acuity rarely &#x0003e;20/100</p></list-item><list-item><p>Almost all affected males have some ID</p></list-item></list>
</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Congenital hypotonia, delayed development, proximal renal tubular dysfunction (renal Fanconi type), progressive chronic renal failure and ESRD after age 10-20 yrs</td>
              </tr>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">Neurofibromatosis type 1</related-object>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">NF1</italic>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Iris Lisch nodules</p></list-item><list-item><p>CG rarely observed</p></list-item></list>
</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Multiple caf&#x000e9; au lait spots, axillary &#x00026; inguinal freckling, cutaneous neurofibromas, learning disabilities in &#x02265;50% of individuals</td>
              </tr>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Nance-Horan syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/302350">302350</ext-link>)</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">NHS</italic>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XL</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Cataract and microcornea</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Skeletal features</td>
              </tr>
              <tr>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Sturge-Weber syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/185300">185300</ext-link>)</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GNAQ</italic>
                </td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 5</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">CG w/associated angle anomalies in &#x02264;60% of affected individuals</td>
                <td headers="hd_h_glc.T.conditionssyndromes_associated_wit_1_1_1_4 hd_h_glc.T.conditionssyndromes_associated_wit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Nevus flammeus of the face, angioma of the meninges</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn>
              <p>XL = X-linked</p>
            </fn>
            <fn>
              <p>WAGR = Wilms tumor-aniridia-genital anomalies-retardation</p>
            </fn>
            <fn>
              <p>ID = intellectual disability</p>
            </fn>
            <fn>
              <p>CG = congenital glaucoma</p>
            </fn>
            <fn>
              <p>ESRD = end-stage renal disease</p>
            </fn>
            <fn id="glc.TF.2.1">
              <label>1. </label>
              <p>Pathogenic variants or deletions in <italic toggle="yes">PAX6</italic> or its control elements are associated with isolated aniridia. Contiguous gene deletions including <italic toggle="yes">PAX6</italic> and <italic toggle="yes">WT1</italic> are associated with aniridia and the risk of one or more additional manifestations of WAGR.</p>
            </fn>
            <fn id="glc.TF.2.2">
              <label>2. </label>
              <p>Anterior segment dysgenesis syndromes are a heterogeneous group of disorders that are usually inherited in an autosomal dominant manner with reduced penetrance.</p>
            </fn>
            <fn id="glc.TF.2.3">
              <label>3. </label>
              <p>
                <xref ref-type="bibr" rid="glc.REF.huang.2015.1111">Huang et al [2015]</xref>
              </p>
            </fn>
            <fn id="glc.TF.2.4">
              <label>4. </label>
              <p>
                <xref ref-type="bibr" rid="glc.REF.ramamurthy.2007.647">Ramamurthy et al [2007]</xref>
              </p>
            </fn>
            <fn id="glc.TF.2.5">
              <label>5. </label>
              <p>Somatic mosaic pathogenic variants in <italic toggle="yes">GNAQ</italic> have been reported in individuals with Sturge-Weber syndrome.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="glc.Management">
        <title>Management</title>
        <sec id="glc.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with primary congenital glaucoma (PCG), examination under anesthesia or sedation is warranted to make a complete assessment of both eyes. The examination includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of intraocular pressure (IOP) within the first few minutes of anesthesia</p>
            </list-item>
            <list-item>
              <p>Measurement of corneal diameter</p>
            </list-item>
            <list-item>
              <p>Examination of the anterior segment</p>
            </list-item>
            <list-item>
              <p>Direct gonioscopy to rule out secondary glaucoma</p>
            </list-item>
            <list-item>
              <p>Dilated fundus examination to evaluate for optic nerve damage</p>
            </list-item>
            <list-item>
              <p>If the cornea is opaque, ultrasound biomicroscopy or optical coherence tomography to aid in evaluating the anterior segment structures</p>
            </list-item>
            <list-item>
              <p>Measurement of axial length</p>
            </list-item>
          </list>
          <p>If the child is examined under anesthesia, consent may be obtained to perform the appropriate surgical procedure after evaluation under anesthesia.</p>
          <p>Consultation with a clinical geneticist and/or genetic counselor is recommended.</p>
        </sec>
        <sec id="glc.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The primary goal of treatment is to decrease IOP to prevent vision-threatening complications including corneal opacification and glaucomatous optic atrophy. Early treatment to control IOP will reverse some of these complications in children. A Cochcrane review analyzed the literature that addressed the surgical management of congenital glaucoma but could not draw any conclusions from the analysis [<xref ref-type="bibr" rid="glc.REF.ghate.2015.cd008213">Ghate &#x00026; Wang 2015</xref>].</p>
          <p><bold>Surgical treatment.</bold> The following approach is based on the work of <xref ref-type="bibr" rid="glc.REF.deluise.1983.1">deLuise &#x00026; Anderson [1983]</xref>, <xref ref-type="bibr" rid="glc.REF.ho.2004.271">Ho &#x00026; Walton [2004]</xref>, <xref ref-type="bibr" rid="glc.REF.bowman.2011.236">Bowman et al [2011]</xref>, <xref ref-type="bibr" rid="glc.REF.sharaawy.2011.s123">Sharaawy &#x00026; Bhartiya [2011]</xref>, and <xref ref-type="bibr" rid="glc.REF.alobeidan.2014.65">Al-Obeidan et al [2014]</xref>.</p>
          <p>PCG is almost always managed surgically. The primary goal of surgery is to eliminate the resistance to aqueous outflow caused by the structural abnormalities in the anterior chamber angle. This goal may be accomplished through an internal approach (goniotomy) or an external approach (trabeculotomy or trabeculectomy).</p>
          <p>In goniotomy, the surgeon visualizes the anterior chamber structures through a special lens (goniolens) to create openings in the trabecular meshwork. The goal of the procedure is to eliminate any resistance imposed by the abnormal trabecular meshwork. A clear cornea is necessary for direct visualization of the anterior chamber structures during this procedure.</p>
          <p>In trabeculotomy, the trabecular meshwork is incised by cannulating Schlemm's canal with a metal probe or suture via an external opening in the sclera.</p>
          <p>In trabeculectomy, a section of trabecular meshwork and Schlemm's canal is removed under a partial thickness sclera flap to create a wound fistula [<xref ref-type="bibr" rid="glc.REF.morales.2013">Morales et al 2013</xref>, <xref ref-type="bibr" rid="glc.REF.chen.2014a.2107">Chen et al 2014a</xref>].</p>
          <p>In deep sclerectomy the dissection of a deep scleral flap, deroofing of Schlemm's canal, and preserving the structural integrity of the trabecular meshwork results in improved aqueous outflow outside the anterior chamber.</p>
          <p>Note: In contrast to goniotomy, deep sclerectomy, trabeculotomy, and trabeculectomy can be performed in individuals with advanced glaucoma and cloudy corneas.</p>
          <p>Glaucoma drainage implants or cyclodestruction may be used to control IOP when initial surgical procedures have failed.</p>
          <p>More than one surgical intervention may be necessary to control IOP; thus, significant morbidity is associated with both PCG and the currently available surgical treatment options. Individuals with milder forms of disease who present later in childhood often do well with a single surgical procedure and have an excellent visual prognosis later in life.</p>
          <p>Clarity of the cornea and other ocular media, control of the ocular dimensions (corneal diameters and axial lengths), and optic nerve damage are important indicators of the course of the disease following surgery. Reported success rates for each (initial) procedure are approximately 80%. Infants with elevated IOP and cloudy corneas at birth have the poorest prognosis. The most favorable outcome is seen in infants in whom surgery is performed between the second and eighth month of life. With increasing age, surgery is less effective in preserving vision.</p>
          <p><bold>Medications.</bold> Beta-blockers (e.g., timolol), parasympathomimetics (e.g., pilocarpine), sympathomimetics (e.g., adrenergic agonists and alpha-2 adrenergic receptor agonists), carbonic anhydrase inhibitors, and prostaglandin agonists have all been used. These medications, particularly the alpha-2 adrenergic receptor agonists, may have severe side effects and must be used with caution in infants and children [<xref ref-type="bibr" rid="glc.REF.maris.2005.461">Maris et al 2005</xref>, <xref ref-type="bibr" rid="glc.REF.papadopoulos.2007.1319">Papadopoulos &#x00026; Khaw 2007</xref>].</p>
          <p>Surgery should not be delayed in an attempt to achieve medical control of IOP.</p>
          <p>Medication may be used preoperatively to lower the IOP to prevent optic nerve damage, to reduce the risk of sudden decompression of the globe, and to clear the cornea for better visualization during examination and surgery.</p>
          <p>Postoperatively, medication may help control IOP until the success of the surgical procedure is established.</p>
          <p>Medical therapy is also used when surgery may be life threatening or has led to incomplete control of the glaucoma [<xref ref-type="bibr" rid="glc.REF.deluise.1983.1">deLuise &#x00026; Anderson 1983</xref>].</p>
          <p><bold>Treatment of refractive errors.</bold> Amblyopia from uncorrected refractive errors often associated with PCG must be treated to obtain optimal visual function.</p>
        </sec>
        <sec id="glc.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Medications such as Phospholine Iodide<sup>&#x000ae;</sup> (echothiophate) need to be discontinued before surgery, especially if succinylcholine is used because of the danger of prolonged apnea.</p>
        </sec>
        <sec id="glc.Surveillance">
          <title>Surveillance</title>
          <p>Lifelong monitoring is necessary to ensure control of IOP to preserve remaining vision and to prevent further loss of vision; the intervals at which monitoring needs to be performed vary depending on the severity of disease and control of IOP.</p>
          <p>Once IOP is controlled and the child is visually rehabilitated, follow up is typically every three months to keep IOP at the "target" level, which depends on the severity of the glaucomatous optic nerve damage and the age of the individual. Standard clinical follow-up tests include optic nerve photography and visual field testing. The complete ophthalmic evaluation often requires examination under anesthesia or sedation in infants and in young and uncooperative children. This process may be challenging to the individual, the family, and the treating physician [<xref ref-type="bibr" rid="glc.REF.deluise.1983.1">deLuise &#x00026; Anderson 1983</xref>, <xref ref-type="bibr" rid="glc.REF.ho.2004.271">Ho &#x00026; Walton 2004</xref>].</p>
        </sec>
        <sec id="glc.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Alpha-2 agonists should be avoided in children in the treatment of elevated IOP because of the risk for apnea and bradycardia.</p>
        </sec>
        <sec id="glc.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Testing at-risk sibs in the neonatal period may be helpful in establishing the diagnosis of PCG early and in avoiding repeated examinations under anesthesia in at-risk young children.</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing alone is appropriate in sibs of affected individuals in whom the pathogenic variant(s) have been identified.</p>
            </list-item>
            <list-item>
              <p>If the PCG-related pathogenic variant(s) have not been identified in an affected family member (i.e., no definitive exclusion of the disease is possible by molecular genetic testing), screening including IOP measurements under anesthesia/sedation may be necessary.</p>
            </list-item>
          </list>
          <p>Note: The literature is unclear as to timing of the onset of glaucoma, especially in families in whom pathogenic variants have been identified. In this high-risk group, it may be appropriate to perform yearly glaucoma screening into young adulthood.</p>
          <p>See <xref ref-type="sec" rid="glc.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="glc.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="glc.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="glc.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Primary congenital glaucoma (PCG) caused by pathogenic variants in <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic> is inherited in an autosomal recessive manner.</p>
          <p>PCG caused by a pathogenic variant in <italic toggle="yes">TEK</italic> is inherited in an apparent autosomal dominant manner.</p>
        </sec>
        <sec id="glc.Risk_to_Family_Members__Autosomal_Re">
          <title>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic>-related PCG are obligate heterozygotes (carriers) for a <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier for a <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic> pathogenic variant.</p>
          <p><bold>Carrier (heterozygote) detection.</bold> Carrier testing for at-risk family members requires prior identification of the <italic toggle="yes">CYP1B1</italic> or <italic toggle="yes">LTBP2</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="glc.Risk_to_Family_Members__Autosomal_Do">
          <title>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>All probands with <italic toggle="yes">TEK</italic>-related PCG reported to date have the disorder as a result of a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic>
<italic toggle="yes">TEK</italic> pathogenic variant include molecular genetic testing.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>All affected individuals reported to date have had a <italic toggle="yes">de novo</italic>
<italic toggle="yes">TEK</italic> pathogenic variant, suggesting a low risk to sibs.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">TEK</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the recurrence risk to sibs is estimated at 1% because of the theoretic possibility of parental germline mosaicism [<xref ref-type="bibr" rid="glc.REF.rahbari.2016.126">Rahbari et al 2016</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">TEK</italic>-related PCG has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members.</bold> Given that all individuals with <italic toggle="yes">TEK</italic>-related PCG reported to date have the disorder as a result of a <italic toggle="yes">de novo</italic> pathogenic variant, the risk to other family members is presumed to be low.</p>
        </sec>
        <sec id="glc.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="glc.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="glc.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CYP1B1</italic>, <italic toggle="yes">LTBP2</italic>, or <italic toggle="yes">TEK</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk for PCG and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="glc.Resources">
        <title>Resources</title>
      </sec>
      <sec id="glc.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="glc.CYP1B1_1">
          <title>
            <italic toggle="yes">CYP1B1</italic>
          </title>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">CYP1B1</italic> spans 12 kb, comprises three exons (exons 2 and 3 are coding exons), and produces a 1,631-base mRNA product. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="glc" object-id="glc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> Nearly 200 pathogenic variants are listed in the Human Gene Mutation Database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hgmd.org">HGMD</ext-link>) (see <related-object source-id="gene" document-id="glc" object-id="glc.molgen.TA">Table A</related-object>), including missense and nonsense variants, small deletions/insertions/duplications, and exon and whole-gene deletions.</p>
          <table-wrap id="glc.T.cyp1b1_pathogenic_variants_discuss" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p><italic toggle="yes">CYP1B1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_glc.T.cyp1b1_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_glc.T.cyp1b1_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_glc.T.cyp1b1_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_glc.T.cyp1b1_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.182G&#x0003e;A&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_glc.T.cyp1b1_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly61Glu</td>
                  <td headers="hd_h_glc.T.cyp1b1_pathogenic_variants_discuss_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000104.3">NM_000104.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000095.2">NP_000095.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_glc.T.cyp1b1_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1159G&#x0003e;A&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_glc.T.cyp1b1_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu387Lys</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="glc.TF.3.1">
                <label>1. </label>
                <p>See <xref ref-type="sec" rid="glc.Prevalence">Prevalence</xref>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> Cytochrome P450 1B1 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids. Cytochrome P450 1B1 localizes to the endoplasmic reticulum and metabolizes procarcinogens including polycyclic aromatic hydrocarbons and 17-&#x003b2;-estradiol [<xref ref-type="bibr" rid="glc.REF.murray.2001.1413">Murray et al 2001</xref>].</p>
          <p><bold>Abnormal gene product.</bold> In silico and in vitro studies have been carried out to determine the effect of <italic toggle="yes">CYP1B1</italic> pathogenic variants on the structure and function of the protein. In vitro studies to determine the effect of <italic toggle="yes">CYP1B1</italic> pathogenic variants on the stability and function of the protein were carried out by <xref ref-type="bibr" rid="glc.REF.jansson.2001.793">Jansson et al [2001]</xref>. The authors studied the effect of two missense variants (p.Gly61Glu and p.Arg469Trp) on the stability and enzymatic activity of <italic toggle="yes">CYP1B1</italic>. It was observed that mutated protein p.Gly61Glu had lost 60% of its stability, while p.Arg469Trp retained about 80% of the stability compared to the wild type. The effects of mutation on protein function were further determined by an enzymatic assay that further confirmed their decreased metabolic activity (50%-70%) for all the substrates when compared to the wild type protein.</p>
        </sec>
        <sec id="glc.LTBP2_1">
          <title>
            <italic toggle="yes">LTBP2</italic>
          </title>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">LTBP2</italic> transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000428.2">NM_000428.2</ext-link> comprises 36 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="glc" object-id="glc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold>
<xref ref-type="bibr" rid="glc.REF.ali.2009.664">Ali et al [2009]</xref> first reported four <italic toggle="yes">LTBP2</italic> missense variants and small deletions that caused PCG in four consanguineous families from Pakistan and in persons of Rom ethnicity. <xref ref-type="bibr" rid="glc.REF.narooienejad.2009.3969">Narooie-Nejad et al [2009]</xref> subsequently reported two <italic toggle="yes">LTBP2</italic> loss-of-function pathogenic variants in Iranian families with PCG.</p>
          <p><bold>Normal gene product.</bold> The encoded protein <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000419.1">NP_000419.1</ext-link>, comprising 1821 amino acids, belongs to the family of latent transforming growth factor (TGF)-beta binding proteins (LTBP), which are extracellular matrix proteins with multi-domain structure. This protein is the largest member of the LTBP family; it possesses unique regions and is the most similar to the fibrillins. It has thus been suggested that the protein may have multiple functions: as a member of the TGF-beta latent complex, as a structural component of microfibrils, and as a mediator of cell adhesion.</p>
          <p><bold>Abnormal gene product.</bold> Pathogenic variants are expected to extensively affect protein structure and function and to interfere with both fibrillin 1 and fibulin 5 binding [<xref ref-type="bibr" rid="glc.REF.narooienejad.2009.3969">Narooie-Nejad et al 2009</xref>].</p>
        </sec>
        <sec id="glc.TEK_1">
          <title>
            <italic toggle="yes">TEK</italic>
          </title>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">TEK</italic> has multiple transcript variants, the longest of which is <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459.4">NM_000459.4</ext-link> which is 4.7 kb in length and comprises 23 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="glc" object-id="glc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> Ten pathogenic variants are listed in HGMD, including missense, nonsense, and splicing variants, small deletions &#x00026; insertions resulting in frameshifts, and one gross deletion of exons 2-4 [<xref ref-type="bibr" rid="glc.REF.souma.2016.2575">Souma et al 2016</xref>].</p>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">TEK</italic> encodes a tyrosine-protein kinase that acts as cell-surface receptor, the angiopoietin-1 receptor. It is expressed almost exclusively in endothelial cells.</p>
          <p><bold>Abnormal gene product.</bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600221?search=tek&#x00026;highlight=tek#15">Souma et al [2016]</ext-link> proposed that gain-of-function pathogenic variants in <italic toggle="yes">TEK</italic> result in venous malformations in nonocular tissues, whereas loss-of-function variants affect anterior chamber vascular development and result in primary congenital glaucoma.</p>
        </sec>
      </sec>
      <sec id="glc.References">
        <title>References</title>
        <sec id="glc.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="glc.Literature_Cited.reflist0">
            <ref id="glc.REF.abuamero.2015.184">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aljasim</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edward</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <article-title>CYP1B1 mutations are a major contributor to juvenile-onset open angle glaucoma in Saudi Arabia.</article-title>
                <source>Ophthalmic Genet.</source>
                <year>2015</year>
                <volume>36</volume>
                <fpage>184</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24099281</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.abuamero.2011.2911">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osman</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mousa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whigham</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allingham</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Obeidan</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Screening of CYP1B1 and LTBP2 genes in Saudi families with primary congenital glaucoma: genotype-phenotype correlation.</article-title>
                <source>Mol Vis.</source>
                <year>2011</year>
                <volume>17</volume>
                <fpage>2911</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22128238</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.acharya.2006.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Acharya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mookherjee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhattacharjee</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandyopadhyay</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daulat Thakur</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhaduri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Primary role of CYP1B1 in Indian juvenile-onset POAG patients.</article-title>
                <source>Mol Vis</source>
                <volume>12</volume>
                <fpage>399</fpage>
                <lpage>404</lpage>
                <pub-id pub-id-type="pmid">16688110</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.akarsu.1996.1199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akarsu</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turacli</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aktan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barsoum-Homsy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevrette</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sayli</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarfarazi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A second locus (GLC3B) for primary congenital glaucoma (Buphthalmos) maps to the 1p36 region.</article-title>
                <source>Hum Mol Genet</source>
                <volume>5</volume>
                <fpage>1199</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">8842741</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.ali.2009.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKibbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riazuddin</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejtmancik</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Firasat</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shires</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilmour</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towns</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azmanov</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherninkova</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jafri</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raashid</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaydjieva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riazuddin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Null mutations in LTBP2 cause primary congenital glaucoma.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>84</volume>
                <fpage>664</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">19361779</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.al_judaibi.2014.445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al Judaibi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Shahwan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edward</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <article-title>Mutations of the CYP1B1 gene in congenital anterior staphylomas.</article-title>
                <source>Clin Ophthalmol.</source>
                <year>2014</year>
                <volume>8</volume>
                <fpage>445</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24591815</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.allingham.2005">
              <mixed-citation publication-type="book">Allingham RR, Damji K, Freeman S, Moroi S, Shafranov G. Congenital glaucomas and developmental glaucomas with associated anomalies. In: Allingham RR, Damji KF, Freedman S, Moroi AE, Rhee DJ, eds. <italic toggle="yes">Shields Textbook of Glaucoma</italic>. 5 ed. Philadelphia, PA: Lippincott Williams &#x00026; Wilkins; 2005:235-71.</mixed-citation>
            </ref>
            <ref id="glc.REF.alobeidan.2014.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Obeidan</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osman</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dewedar</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kestelyn</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mousa</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia.</article-title>
                <source>Acta Ophthalmol.</source>
                <year>2014</year>
                <volume>92</volume>
                <fpage>65</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">23241279</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.alzuhairy.2015.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alzuhairy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Shahwan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edward</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <article-title>A novel CYP1B1 mutation with congenital glaucoma and total aniridia.</article-title>
                <source>Ophthalmic Genet.</source>
                <year>2015</year>
                <volume>36</volume>
                <fpage>89</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">24001018</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.bejjani.1998.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bejjani</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomey</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dueker</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astle</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otterud</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>62</volume>
                <fpage>325</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">9463332</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.bejjani.2000.367">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bejjani</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockton</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomey</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dueker</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astle</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>367</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">10655546</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.belmouden.2002.334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Belmouden</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamdani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaghloul</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amraoui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadifi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akhayat</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garchon</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A novel frameshift founder mutation in the cytochrome P450 1B1 (CYP1B1) gene is associated with primary congenital glaucoma in Morocco.</article-title>
                <source>Clin Genet</source>
                <volume>62</volume>
                <fpage>334</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12372064</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.berraho.2015.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berraho</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fritez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Annas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bencherifa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaboun</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilal</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-phenotype correlation in Moroccan patients with primary congenital glaucoma.</article-title>
                <source>J Glaucoma.</source>
                <year>2015</year>
                <volume>24</volume>
                <fpage>297</fpage>
                <lpage>305</lpage>
                <pub-id pub-id-type="pmid">25826643</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.bowman.2011.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bowman</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickerson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mwende</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khaw</surname>
                    <given-names>PT</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Outcomes of goniotomy for primary congenital glaucoma in East Africa.</article-title>
                <source>Ophthalmology.</source>
                <volume>118</volume>
                <fpage>236</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21292108</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.chakrabarti.2010.4083">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chakrabarti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghanekar</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandal</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parikh</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majumder</surname>
                    <given-names>PP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A polymorphism in the CYP1B1 promoter is functionally associated with primary congenital glaucoma.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>19</volume>
                <fpage>4083</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">20660114</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.chakrabarti.2006.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chakrabarti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandal</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parikh</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majumder</surname>
                    <given-names>PP</given-names>
                  </name>
                </person-group>
                <article-title>Globally, CYP1B1 mutations in primary congenital glaucoma are strongly structured by geographic and haplotype backgrounds.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <year>2006</year>
                <volume>47</volume>
                <fpage>43</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16384942</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.chen.2014a.2107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francis</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Junk</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>SC</given-names>
                  </name>
                </person-group>
                <article-title>Pediatric glaucoma surgery: a report by the American Academy of Ophthalmology.</article-title>
                <source>Ophthalmology.</source>
                <year>2014a</year>
                <volume>121</volume>
                <fpage>2107</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">25066765</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.chen.2014b.246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>X.</given-names>
                  </name>
                </person-group>
                <article-title>CYP1B1 genotype influences the phenotype in primary congenital glaucoma and surgical treatment.</article-title>
                <source>Br J Ophthalmol.</source>
                <year>2014b</year>
                <volume>98</volume>
                <fpage>246</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">24227805</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.chitsazian.2007.382">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chitsazian</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tusi</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elahi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saroei</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanati</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yazdani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pakravan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilforooshan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eslami</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehrjerdi</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareei</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabbarvand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdolahi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasheyee</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Etemadi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeghi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banoei</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghafarzadeh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohani</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rismanchian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorstenson</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarfarazi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>CYP1B1 mutation profile of Iranian primary congenital glaucoma patients and associated haplotypes.</article-title>
                <source>J Mol Diagn.</source>
                <volume>9</volume>
                <fpage>382</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">17591938</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.curry.2004.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Curry</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daou</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermanns</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molinari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bejjani</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cytochrome P4501B1 mutations cause only part of primary congenital glaucoma in Ecuador.</article-title>
                <source>Ophthalmic Genet</source>
                <volume>25</volume>
                <fpage>3</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15255109</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.dandona.2001.908">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dandona</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dandona</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srinivas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giridhar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilas</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prasad</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCarty</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>GN</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Blindness in the Indian state of Andhra Pradesh.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>42</volume>
                <fpage>908</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">11274066</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.della_paolera.2010.176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Della Paolera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vasconcellos</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Umbelino</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasahara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocha</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richeti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavares</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Melo</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>CYP1B1 gene analysis in primary congenital glaucoma Brazilian patients: novel mutations and association with poor prognosis.</article-title>
                <source>J Glaucoma.</source>
                <volume>19</volume>
                <fpage>176</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">19528825</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.deluise.1983.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>deLuise</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <article-title>Primary infantile glaucoma (congenital glaucoma).</article-title>
                <source>Surv Ophthalmol.</source>
                <year>1983</year>
                <volume>28</volume>
                <fpage>1</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">6353647</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.de_melo.2015.e0127147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Melo</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandal</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavares</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vasconcellos</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senthil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sallum</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betinjane</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moura</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paula</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarfarazi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paolera</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finzi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferraz</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belfort</surname>
                    <given-names>R</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Chakrabarti</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-phenotype correlations in CYP1B1-associated primary congenital glaucoma patients representing two large cohorts from India and Brazil.</article-title>
                <source>PLoS One.</source>
                <year>2015</year>
                <volume>10</volume>
                <fpage>e0127147</fpage>
                <pub-id pub-id-type="pmid">25978063</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.firasat.2008.1659">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Firasat</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riazuddin</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejtmancik</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riazuddin</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Primary congenital glaucoma localizes to chromosome 14q24.2-24.3 in two consanguineous Pakistani families.</article-title>
                <source>Mol Vis.</source>
                <volume>14</volume>
                <fpage>1659</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">18776954</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.ghate.2015.cd008213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ghate</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <article-title>Surgical interventions for primary congenital glaucoma.</article-title>
                <source>Cochrane Database Syst Rev.</source>
                <year>2015</year>
                <volume>1</volume>
                <fpage>CD008213</fpage>
                <pub-id pub-id-type="pmid">25636153</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.ho.2004.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walton</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Primary congenital glaucoma: 2004 update.</article-title>
                <source>J Pediatr Ophthalmol Strabismus</source>
                <volume>41</volume>
                <fpage>271</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">15478740</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.huang.2015.1111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jia</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <article-title>Mutation analysis of the genes associated with anterior segment dysgenesis, microcornea and microphthalmia in 257 patients with glaucoma.</article-title>
                <source>Int J Mol Med.</source>
                <year>2015</year>
                <volume>36</volume>
                <fpage>1111</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">26310487</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.jansson.2001.793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jansson</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoilov</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarfarazi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schenkman</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism.</article-title>
                <source>Pharmacogenetics</source>
                <volume>11</volume>
                <fpage>793</fpage>
                <lpage>801</lpage>
                <pub-id pub-id-type="pmid">11740343</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.kaur.2005.335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reddy</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukhopadhyay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandal</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasnain</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balasubramanian</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrabarti</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Myocilin gene implicated in primary congenital glaucoma.</article-title>
                <source>Clin Genet</source>
                <volume>67</volume>
                <fpage>335</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15733270</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.khan.2011.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AO</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Conditions that can be mistaken as early childhood glaucoma.</article-title>
                <source>Ophthalmic Genet.</source>
                <volume>32</volume>
                <fpage>129</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">21341968</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.khan.2011.2570">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldahmesh</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkuraya</surname>
                    <given-names>FS</given-names>
                  </name>
                </person-group>
                <article-title>Congenital megalocornea with zonular weakness and childhood lens-related secondary glaucoma: a distinct phenotype caused by recessive LTBP2 mutations.</article-title>
                <source>Mol Vis.</source>
                <year>2011</year>
                <volume>17</volume>
                <fpage>2570</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22025892</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.kumar.2010.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duvvari</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prabhakaran</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shetty</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murthy</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanton</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A homozygous mutation in LTBP2 causes isolated microspherophakia.</article-title>
                <source>Hum Genet.</source>
                <volume>128</volume>
                <fpage>365</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">20617341</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.maris.2005.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maris</surname>
                    <given-names>PJ</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Mandal</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Netland</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Medical therapy of pediatric glaucoma and glaucoma in pregnancy.</article-title>
                <source>Ophthalmol Clin North Am.</source>
                <volume>18</volume>
                <fpage>461</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16055002</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.mashima.2001.2211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mashima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sergeev</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtake</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanino</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyata</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aihara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanihara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inatani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azuma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araie</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Novel cytochrome P4501B1 (CYP1B1) gene mutations in Japanese patients with primary congenital glaucoma.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>42</volume>
                <fpage>2211</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11527932</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.melki.2004.647">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Melki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomb</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefort</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000e9;zin</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garchon</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <article-title>CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma.</article-title>
                <source>J Med Genet.</source>
                <year>2004</year>
                <volume>41</volume>
                <fpage>647</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15342693</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.micheal.2015.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Micheal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayub</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zafar</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akhtar</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Islam</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qamar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>den Hollander</surname>
                    <given-names>AI</given-names>
                  </name>
                </person-group>
                <article-title>Identification of novel CYP1B1 gene mutations in patients with primary congenital and primary open-angle glaucoma.</article-title>
                <source>Clin Exp Ophthalmol.</source>
                <year>2015</year>
                <volume>43</volume>
                <fpage>31</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25091052</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.micheal.2016.e0159259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Micheal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddiqui</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zafar</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iqbal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>den Hollander</surname>
                    <given-names>AI</given-names>
                  </name>
                </person-group>
                <article-title>Identification of novel variants in LTBP2 and PXDN using whole-exome sequencing in developmental and congenital glaucoma.</article-title>
                <source>PLoS One.</source>
                <year>2016</year>
                <volume>11</volume>
                <fpage>e0159259</fpage>
                <pub-id pub-id-type="pmid">27409795</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.morales.2013">
              <mixed-citation publication-type="other">Morales J, Al Shahwan S, Al Odhayb S, Al Jadaan I, Edward DP. Current surgical options for the management of pediatric glaucoma. J Ophthalmol. 2013;2013:763735.</mixed-citation>
            </ref>
            <ref id="glc.REF.murray.2001.1413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lake</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Springall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowey</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boobis</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gooderham</surname>
                    <given-names>NJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man.</article-title>
                <source>Carcinogenesis.</source>
                <volume>22</volume>
                <fpage>1413</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">11532863</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.narooienejad.2009.3969">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Narooie-Nejad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paylakhi</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shojaee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazlali</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezaei Kanavi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilforushan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yazdani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babrzadeh</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronaghi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elahi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pais&#x000e1;n-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Loss of function mutations in the gene encoding latent transforming growth factor beta binding protein 2, LTBP2, cause primary congenital glaucoma.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>18</volume>
                <fpage>3969</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">19656777</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.panicker.2002.1358">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Panicker</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reddy</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandal</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagarajaram</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasnain</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balasubramanian</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Identification of novel mutations causing familial primary congenital glaucoma in Indian pedigrees.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>43</volume>
                <fpage>1358</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">11980847</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.papadopoulos.2007.1319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Papadopoulos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khaw</surname>
                    <given-names>PT</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Advances in the management of paediatric glaucoma.</article-title>
                <source>Eye (Lond)</source>
                <volume>21</volume>
                <fpage>1319</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">17914435</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.pl_silov_.1998.30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pl&#x000e1;silov&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fer&#x000e1;kov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000e1;dasi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pol&#x000e1;kov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerinec</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ott</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fer&#x000e1;k</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Linkage of autosomal recessive primary congenital glaucoma to the GLC3A locus in Roms (Gypsies) from Slovakia.</article-title>
                <source>Hum Hered.</source>
                <volume>48</volume>
                <fpage>30</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9463798</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.pl_silov_.1999.290">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pl&#x000e1;silov&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoilov</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarfarazi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000e1;dasi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fer&#x000e1;kov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fer&#x000e1;k</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma.</article-title>
                <source>J Med Genet.</source>
                <volume>36</volume>
                <fpage>290</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10227395</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.rahbari.2016.126">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rahbari</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuster</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindsay</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardwick</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexandrov</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turki</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dominiczak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porteous</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratton</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurles</surname>
                    <given-names>ME</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Timing, rates and spectra of human germline mutation.</article-title>
                <source>Nat Genet.</source>
                <year>2016</year>
                <volume>48</volume>
                <fpage>126</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">26656846</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.ramamurthy.2007.647">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramamurthy</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sachdeva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandal</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vemuganti</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sangwan</surname>
                    <given-names>VS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Coexistent congenital hereditary endothelial dystrophy and congenital glaucoma.</article-title>
                <source>Cornea</source>
                <volume>26</volume>
                <fpage>647</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17592310</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.sharaawy.2011.s123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sharaawy</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhartiya</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Surgical management of glaucoma: evolving paradigms.</article-title>
                <source>Indian J Ophthalmol.</source>
                <volume>59</volume>
                <supplement>Suppl</supplement>
                <fpage>S123</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">21150024</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.sihota.2006.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sihota</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sachdeva</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Distribution and determinants of intraocular pressure in a normal pediatric population.</article-title>
                <source>J Pediatr Ophthalmol Strabismus.</source>
                <volume>43</volume>
                <fpage>14</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16491720</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.sitorus.2003.e9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sitorus</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ardjo</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preising</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>CYP1B1 gene analysis in primary congenital glaucoma in Indonesian and European patients.</article-title>
                <source>J Med Genet.</source>
                <volume>40</volume>
                <fpage>e9</fpage>
                <pub-id pub-id-type="pmid">12525557</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.souma.2016.2575">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Souma</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tompson</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomson</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siggs</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kizhatil</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Limviphuvadh</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whisenhunt</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maurer-Stroh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanovitch</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaydjieva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azmanov</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finzi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mauri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Javadiyan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Souzeau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hewitt</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloss</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burdon</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruddle</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran-Viet</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiggs</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasutto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quaggin</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>TL</given-names>
                  </name>
                </person-group>
                <article-title>Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.</article-title>
                <source>J Clin Invest.</source>
                <year>2016</year>
                <volume>126</volume>
                <fpage>2575</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">27270174</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.stoilov.2002.1820">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stoilov</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasconcellos</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melo</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betinjane</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carani</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oltrogge</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarfarazi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Molecular genetics of primary congenital glaucoma in Brazil.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2002</year>
                <volume>43</volume>
                <fpage>1820</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12036985</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.stoilov.2002">
              <mixed-citation publication-type="confproc">Stoilov IR, Sarfarazi M. The third genetic locus (GLC3C) for primary congenital glaucoma (PCG) maps to chromosome 14q24.3. Abstract 3015. Fort Lauderdale, FL: Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting; 2002.</mixed-citation>
            </ref>
            <ref id="glc.REF.vincent.2002.448">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billingsley</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priston</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trope</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams-Lyn</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heon</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene.</article-title>
                <source>Am J Hum Genet</source>
                <volume>70</volume>
                <fpage>448</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11774072</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.walton.1998">
              <mixed-citation publication-type="book">Walton DS. Congenital glaucoma. In: Traboulsi EI, ed. <italic toggle="yes">Genetic Diseases of the Eye.</italic> New York, NY: Oxford University Press; 1998:177-82.</mixed-citation>
            </ref>
            <ref id="glc.REF.walton.2005.333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walton</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsavounidou</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Newborn primary congenital glaucoma: 2005 update.</article-title>
                <source>J Pediatr Ophthalmol Strabismus</source>
                <volume>42</volume>
                <fpage>333</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">16382557</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.zhuo.2006.1210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhuo</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>YT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ge</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Analysis of MYOC gene mutation in a Chinese glaucoma family with primary open-angle glaucoma and primary congenital glaucoma.</article-title>
                <source>Chin Med J (Engl)</source>
                <volume>119</volume>
                <fpage>1210</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16863615</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="glc.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="glc.Suggested_Reading.reflist0">
            <ref id="glc.REF.fan.2010.3064">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiggs</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Glaucoma: genes, phenotypes, and new directions for therapy.</article-title>
                <source>J Clin Invest.</source>
                <volume>120</volume>
                <fpage>3064</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">20811162</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.pan.2011.s19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varma</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Natural history of glaucoma.</article-title>
                <source>Indian J Ophthalmol.</source>
                <volume>59</volume>
                <supplement>Suppl</supplement>
                <fpage>S19</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">21150029</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.rao.2011.s31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagireddy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrabarti</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Complex genetic mechanisms in glaucoma: an overview.</article-title>
                <source>Indian J Ophthalmol.</source>
                <volume>59</volume>
                <supplement>Suppl</supplement>
                <fpage>S31</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">21150032</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.razeghinejad.2011.e39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Razeghinejad</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spaeth</surname>
                    <given-names>GL</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A history of the surgical management of glaucoma.</article-title>
                <source>Optom Vis Sci.</source>
                <volume>88</volume>
                <fpage>E39</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">21131879</pub-id>
              </element-citation>
            </ref>
            <ref id="glc.REF.sheffield">
              <mixed-citation publication-type="web">Sheffield VC, Alward WLM, Stone EM. The glaucomas. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 242. McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="glc.REF.vijaya.2011.s131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vijaya</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manish</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronnie</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shantha</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Management of complications in glaucoma surgery.</article-title>
                <source>Indian J Ophthalmol.</source>
                <volume>59</volume>
                <supplement>Suppl</supplement>
                <fpage>S131</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21150025</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="glc.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="glc.Author_History">
          <title>Author History</title>
          <p>Khaled K Abu-Amero, PhD, FRCPath (2011-present)Bassem A Bejjani, MD, FACMG; Washington State University (2004-2011)Deepak P Edward, MD (2004-present)</p>
        </sec>
        <sec id="glc.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>17 August 2017 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 March 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>25 August 2011 (cd) Revision: sequence analysis of <italic toggle="yes">LTBP2</italic> and deletion/duplication analysis of <italic toggle="yes">CYP1B1</italic> available clinically as listed in the GeneTests Laboratory Directory</p>
            </list-item>
            <list-item>
              <p>21 July 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 December 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 September 2004 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>3 June 2004 (bab) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
